Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Pujol

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Cell Cycle (Georgetown, Tex.)|June 8, 2012
Decreased efficiency of MSH6 mRNA polyadenylation linked to a 20-base-pair duplication in Lynch syndrome familiesAdrien Decorsière, Christine Toulas, Françoise Fouque, et al.
Parasitology|November 16, 2019
The evolution of resistance and tolerance as cancer defencesFrédéric Thomas, Mathieu Giraudeau, Flora Gouzerh, et al.
Elife|March 30, 2021
Group phenotypic composition in cancerJean-Pascal Capp, James DeGregori, Aurora M Nedelcu, et al.
Molecular Genetics & Genomic Medicine|October 12, 2018
Role of the general practitioner in the care of BRCA1 and BRCA2 mutation carriers: General practitioner and patient perspectivesPierre Vande Perre, Daniel Toledano, Carole Corsini, et al.
Cancers|August 9, 2020
Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian CancerMichel Fabbro, Pierre-Emmanuel Colombo, Cristina Marinella Leaha, et al.
Evolutionary Applications|November 24, 2021
On the need for integrating cancer into the One Health perspectiveAntoine M Dujon, Joel S Brown, Delphine Destoumieux-Garzón, et al.
Journal of Medical Genetics|January 9, 2025
Li-Fraumeni syndrome: a germline <i>TP53</i> splice variant reveals a novel physiological alternative transcriptJeanne Louis, Marion Rolain, Corentin Levacher, et al.
Oncotarget|June 2, 2016
Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutationsLaudine Communal, Myriam Vilasco, Justine Hugon-Rodin, et al.
International Journal of Molecular Sciences|January 10, 2026
Quantitative ctDNA Profiling of <i>RAS</i> Mutations as a Prognostic Biomarker in Metastatic Colorectal CancerBenoist Chibaudel, Elisabeth Carola, Hamid Mekranter, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Ovarian Clear Cell Carcinoma in Cowden SyndromeKevin Yauy, Marion Imbert-Bouteille, Virginie Bubien, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Cell Cycle (Georgetown, Tex.)|June 8, 2012
Decreased efficiency of MSH6 mRNA polyadenylation linked to a 20-base-pair duplication in Lynch syndrome familiesAdrien Decorsière, Christine Toulas, Françoise Fouque, et al.
Parasitology|November 16, 2019
The evolution of resistance and tolerance as cancer defencesFrédéric Thomas, Mathieu Giraudeau, Flora Gouzerh, et al.
Elife|March 30, 2021
Group phenotypic composition in cancerJean-Pascal Capp, James DeGregori, Aurora M Nedelcu, et al.
Molecular Genetics & Genomic Medicine|October 12, 2018
Role of the general practitioner in the care of BRCA1 and BRCA2 mutation carriers: General practitioner and patient perspectivesPierre Vande Perre, Daniel Toledano, Carole Corsini, et al.
Cancers|August 9, 2020
Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian CancerMichel Fabbro, Pierre-Emmanuel Colombo, Cristina Marinella Leaha, et al.
Evolutionary Applications|November 24, 2021
On the need for integrating cancer into the One Health perspectiveAntoine M Dujon, Joel S Brown, Delphine Destoumieux-Garzón, et al.
Journal of Medical Genetics|January 9, 2025
Li-Fraumeni syndrome: a germline <i>TP53</i> splice variant reveals a novel physiological alternative transcriptJeanne Louis, Marion Rolain, Corentin Levacher, et al.
Oncotarget|June 2, 2016
Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutationsLaudine Communal, Myriam Vilasco, Justine Hugon-Rodin, et al.
International Journal of Molecular Sciences|January 10, 2026
Quantitative ctDNA Profiling of <i>RAS</i> Mutations as a Prognostic Biomarker in Metastatic Colorectal CancerBenoist Chibaudel, Elisabeth Carola, Hamid Mekranter, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Ovarian Clear Cell Carcinoma in Cowden SyndromeKevin Yauy, Marion Imbert-Bouteille, Virginie Bubien, et al.
Pageof 10